Gracell Biotechnologies Inc. (GRCL) CEO Dr. William Cao on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
Gracell Biotechnologies Inc. - American Depositary Shares (GRCL)
Company Research
Source: Seeking Alpha
Gracell Biotechnologies Inc. (NASDAQ:GRCLCompany ParticipantsDr. Kevin Xie - CFODr. William Cao - Founder and CEODr. Wendy Li - Chief Medical OfficerConference Call ParticipantsJoe Catanzaro - Piper SandlerJustin Zelin - BTIGKelly Shi - JefferiesJames Shin - Wells FargoOperatorLadies and gentlemen, thank you for standing by. Welcome to Gracell Biotechnologies Second Quarter 2022 Conference Call. At this time, all participants are in listen-only mode. After opening remarks, we will open the call for your questions. Instructions for queuing up will be given at that time.I will now turn the conference call over to Dr. Kevin Xie, CFO. Please go ahead.Good morning, and welcome to Gracell's second quarter 2022 corporate update conference call and webcast. With me today are Gracell's Founder and the Chief Executive Officer, Dr. William Cao; and our Chief Medical Officer, Dr. Wendy Li.We're excited to discuss our innovative technologies and a rich clinical pipeline of CAR-T therapies on today
Show less
Read more
Impact Snapshot
Event Time:
GRCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRCL alerts
High impacting Gracell Biotechnologies Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GRCL
News
- Gracell Biotechnologies Inc. (NASDAQ: GRCL) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $10.25 price target on the stock, down previously from $11.00.MarketBeat
- Gracell Biotechnologies Acquisition CompletedGlobeNewswire
- Gracell Biotechnologies Announces Shareholders’ Approval of Merger AgreementGlobeNewswire
GRCL
Sec Filings
- 2/22/24 - Form 25-NSE
- 2/22/24 - Form 6-K
- 2/20/24 - Form 6-K
- GRCL's page on the SEC website